Xcout IntelModus Therapeutics
Modus Therapeutics AB is a Swedish clinical-stage biotechnology company developing sevuparin, a proprietary polysaccharide drug candidate with anti-adhesive and anti-inflammatory…
The full profile of Modus Therapeutics
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Modus Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Modus Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.